The role of anticholinergics in bronchoscopy: A randomized clinical trial

Clayton T. Cowl, Udaya B.S. Prakash, Becky R. Kruger

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


Background: Anticholinergic medications have been utilized frequently prior to bronchoscopy and are thought to facilitate the drying of secretions to limit the amount of required topical anesthetic on the airway mucosa, prevent cardiac arrhythmias during the procedure, and increase patient comfort. Objective: To determine if atropine or glycopyrrolate, two anticholinergic agents utilized most frequently in this setting, have any significant role for this purpose. Design: Double- blind, placebo-controlled study, in which patients were randomly selected to receive atropine (0.01 mg/kg body weight, IM injection), glycopyrrolate (0.005 mg/kg, IM injection), or saline solution placebo (approximately 2 mL, IM injection) 15 to 45 min prior to being sedated with midazolam until judged to be lightly sedated. Setting: A large academic teaching hospital in the midwestern United States. Participants: Two hundred seventeen outpatients referred for bronchoscopy who satisfied inclusion and exclusion criteria. Measurements and results: Using a modified visual analog scale (0 to 100 mm), the bronchoscopist and the nurse anesthetist estimated the antisialagogic effect, effectiveness in cough suppression, and overall patient comfort during the procedure. The patients completed a similar questionnaire after recovering from the procedure. Patients were also monitored for complications (cardiac arrhythmias, oxygen desaturation, hypertension, wheezing, or coughing severe enough to curtail the procedure). There was no significant difference found among atropine, glycopyrrolate, and placebo for the primary end point of secretion control. In addition, there was no difference found between either medication and placebo for effectiveness of cough suppression, amount of topical anesthetic used, complication rates, or overall patient comfort. Conclusion: The use of anticholinergic agents prior to bronchoscopy did not affect performance of bronchoscopy or complication rates, and there was no appreciable benefit from the resultant reduction in airway secretions in a population of patients receiving concurrent sedation with benzodiazepines.

Original languageEnglish (US)
Pages (from-to)188-192
Number of pages5
Issue number1
StatePublished - 2000


  • Anticholinergics
  • Antisialagogue
  • Atropine
  • Bronchoscopy
  • Glycopyrrolate
  • Midaz olam
  • Premedication

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The role of anticholinergics in bronchoscopy: A randomized clinical trial'. Together they form a unique fingerprint.

Cite this